144 related articles for article (PubMed ID: 10626174)
41. Perforating veins - a parameter of recurrence of esophageal varices.
Saihong Z; Xunyang L; Feizhou H; Wanping N; Bo L; Reizheng L; Lifeng C; Wei W; Minshi Y; Shuping R
Rom J Gastroenterol; 2003 Jun; 12(2):119-21. PubMed ID: 12853998
[TBL] [Abstract][Full Text] [Related]
42. [Endoscopic sclerosing in the prevention of recurrent esophageal variceal bleeding].
Li H; Yang W; Chen H
Zhonghua Wai Ke Za Zhi; 1996 Mar; 34(3):154-6. PubMed ID: 9387669
[TBL] [Abstract][Full Text] [Related]
43. Sequential changes of esophageal motility after endoscopic injection sclerotherapy or variceal ligation for esophageal variceal bleeding: a scintigraphic study.
Hou MC; Yen TC; Lin HC; Kuo BI; Chen CH; Lee FY; Liu RS; Chang FY; Lee SD
Am J Gastroenterol; 1997 Oct; 92(10):1875-8. PubMed ID: 9382056
[TBL] [Abstract][Full Text] [Related]
44. Computed tomography following endoscopic sclerotherapy of esophageal varices.
Ikezoe J; Morimoto S; Akira M; Arisawa J; Takashima S; Tomoda K; Nakanishi K; Kadowaki K; Kozuka T; Shiozaki H
Acta Radiol; 1987; 28(4):415-20. PubMed ID: 2958055
[TBL] [Abstract][Full Text] [Related]
45. Endoscopic ultrasonograph evaluation of vascular structures in the gastric cardia predicts esophageal variceal recurrence following endoscopic treatment.
Seno H; Konishi Y; Wada M; Fukui H; Okazaki K; Chiba T
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):227-31. PubMed ID: 16460478
[TBL] [Abstract][Full Text] [Related]
46. Treatment of bleeding esophageal varices with cyanoacrylate and polidocanol, or polidocanol alone: results of a prospective study in an unselected group of patients with cirrhosis of the liver.
Lux G; Retterspitz M; Stabenow-Lohbauer U; Langer M; Altendorf-Hofmann A; Bozkurt T
Endoscopy; 1997 May; 29(4):241-6. PubMed ID: 9255525
[TBL] [Abstract][Full Text] [Related]
47. Hassab operation with intraoperative endoscopic injection sclerotherapy ("Hassab-EIS") for esophagogastric varices: with an autopsied case after excessive gastric vascular damage.
Nakamura H; Goseki N; Dobashi Y; Igari T; Endo M
Hepatogastroenterology; 1996; 43(10):980-6. PubMed ID: 8884324
[TBL] [Abstract][Full Text] [Related]
48. Comparison of characteristics of recurrent esophageal varices after endoscopic ligation versus endoscopic ligation plus sclerotherapy.
Yoshida H; Tajiri T; Mamada Y; Taniai N; Hirakata A; Kawano Y; Mizuguchi Y; Shimizu T; Takahashi T
Hepatogastroenterology; 2004; 51(56):457-61. PubMed ID: 15086182
[TBL] [Abstract][Full Text] [Related]
49. Endoscopic submucosal dissection combined with endoscopic injection sclerotherapy for early gastric cancer on gastric fundal varices.
Uno K; Iijima K; Koike T; Abe Y; Asano N; Yokosawa S; Imatani A; Shimosegawa T
Surg Laparosc Endosc Percutan Tech; 2012 Aug; 22(4):e226-9. PubMed ID: 22874708
[TBL] [Abstract][Full Text] [Related]
50. [Therapeutic modality for esophago-gastric varices analyzed by endoscopic ultrasonography].
Nakamura H; Dobashi Y; Inoue H; Kawano T; Goseki N; Endo M; Sugihara K
Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):1147-9. PubMed ID: 1470131
[TBL] [Abstract][Full Text] [Related]
51. Endoscopic sclerotherapy of bleeding esophageal varices. A comparative study of results in patients with schistosomiasis and cirrhosis.
Sakai P; Boaventura S; Capacci ML; Macedo TM; Ishioka SZ
Endoscopy; 1988 Jul; 20(4):134-6. PubMed ID: 3263266
[TBL] [Abstract][Full Text] [Related]
52. Endoscopic injection sclerotherapy using a transparent overtube with intraluminal negative pressure (np-EIS) for esophageal varices.
Kawano T; Nakamura H; Inoue H; Endo M
Surg Endosc; 1990; 4(1):15-7. PubMed ID: 2315820
[TBL] [Abstract][Full Text] [Related]
53. [Experiences with endoscopic sclerosing of esophageal varices].
Zipprich B; Hesse R; Schwesinger G; Nilius R
Dtsch Z Verdau Stoffwechselkr; 1984; 44(5):209-18. PubMed ID: 6334603
[TBL] [Abstract][Full Text] [Related]
54. Sequential esophageal motility studies after endoscopic injection sclerotherapy: a prospective investigation.
Grande L; Planas R; Lacima G; Boix J; Ros E; Esteve M; Morillas R; Gasull MA
Am J Gastroenterol; 1991 Jan; 86(1):36-40. PubMed ID: 1986552
[TBL] [Abstract][Full Text] [Related]
55. [Endoscopic sclerosing of esophageal varices--technique, possibilities and limits of the method].
Zipprich B; Nilius R
Z Gesamte Inn Med; 1992 Aug; 47(8):331-6. PubMed ID: 1413925
[TBL] [Abstract][Full Text] [Related]
56. Combined ligation and sclerotherapy versus ligation alone for eradication of bleeding esophageal varices: a randomized and prospective trial.
Djurdjevic D; Janosevic S; Dapcevic B; Vukcevic V; Djordjevic D; Svorcan P; Grgov S
Endoscopy; 1999 May; 31(4):286-90. PubMed ID: 10376453
[TBL] [Abstract][Full Text] [Related]
57. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices.
Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K
Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669
[TBL] [Abstract][Full Text] [Related]
58. Magnetic resonance angiography for monitoring prophylactic endoscopic treatment of high risk esophageal varices.
Imazu H; Matsui T; Noguchi R; Asada K; Miyamoto Y; Kawata M; Nakayama M; Matsuo N; Matsumura M; Fukui H
Endoscopy; 2000 Oct; 32(10):766-72. PubMed ID: 11068835
[TBL] [Abstract][Full Text] [Related]
59. [Endoscopic sclerotherapy and esophageal varices].
Berclaz R; de Peyer R; Miazza B; Laszlo A; Cunningham M; Dederding JP; Loup R; Loizeau E
Schweiz Med Wochenschr; 1988 Oct; 118(41):1476-81. PubMed ID: 3266368
[TBL] [Abstract][Full Text] [Related]
60. Recurrence factors studied by percutaneous transhepatic portography before and after endoscopic sclerotherapy for esophageal varices.
Takase Y; Shibuya S; Chikamori F; Orii K; Iwasaki Y
Hepatology; 1990 Mar; 11(3):348-52. PubMed ID: 2312049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
